An Open‐Label, Single‐Arm, Two‐Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas.

Published in:

Oncologist, 2020, v. 25, n. 5, p. e782, doi. 10.1634/theoncologist.2019-0490

By:

• Chen, Ming‐Huang;
• Chou, Wen‐Chi;
• Hsiao, Chin‐Fu;
• Jiang, Shih Sheng;
• Tsai, Hui‐Jen;
• Liu, Yi‐Chang;
• Hsu, Chiun;
• Shan, Yan‐Shen;
• Hung, Yi‐Ping;
• Hsich, Chia‐Hsun;
• Chiu, Chao‐Hua;
• Liu, Ta‐Chih;
• Cho, Shih‐Feng;
• Liu, Tsang‐Wu;
• Chao, Yee

Publication type:

Article